GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (FRA:46K) » Definitions » Cyclically Adjusted Price-to-FCF

iRadimed (FRA:46K) Cyclically Adjusted Price-to-FCF : 71.43 (As of Jun. 04, 2025)


View and export this data going back to 2019. Start your Free Trial

What is iRadimed Cyclically Adjusted Price-to-FCF?

As of today (2025-06-04), iRadimed's current share price is €50.00. iRadimed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €0.70. iRadimed's Cyclically Adjusted Price-to-FCF for today is 71.43.

The historical rank and industry rank for iRadimed's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:46K' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 47.9   Med: 69.45   Max: 87.26
Current: 78.85

During the past years, iRadimed's highest Cyclically Adjusted Price-to-FCF was 87.26. The lowest was 47.90. And the median was 69.45.

FRA:46K's Cyclically Adjusted Price-to-FCF is ranked worse than
78.23% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 36.435 vs FRA:46K: 78.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

iRadimed's adjusted free cash flow per share data for the three months ended in Mar. 2025 was €0.027. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.70 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


iRadimed Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for iRadimed's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Cyclically Adjusted Price-to-FCF Chart

iRadimed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 48.43 75.33 72.86

iRadimed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.40 63.79 69.83 72.86 69.39

Competitive Comparison of iRadimed's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, iRadimed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where iRadimed's Cyclically Adjusted Price-to-FCF falls into.


;
;

iRadimed Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

iRadimed's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=50.00/0.70
=71.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, iRadimed's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.027/134.9266*134.9266
=0.027

Current CPI (Mar. 2025) = 134.9266.

iRadimed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.118 100.684 0.158
201509 0.163 100.392 0.219
201512 0.169 99.792 0.229
201603 0.142 100.470 0.191
201606 0.062 101.688 0.082
201609 0.246 101.861 0.326
201612 0.147 101.863 0.195
201703 -0.037 102.862 -0.049
201706 0.009 103.349 0.012
201709 0.119 104.136 0.154
201712 0.090 104.011 0.117
201803 0.106 105.290 0.136
201806 0.103 106.317 0.131
201809 0.047 106.507 0.060
201812 0.247 105.998 0.314
201903 0.041 107.251 0.052
201906 0.175 108.070 0.218
201909 0.224 108.329 0.279
201912 0.271 108.420 0.337
202003 0.071 108.902 0.088
202006 0.044 108.767 0.055
202009 0.083 109.815 0.102
202012 0.157 109.897 0.193
202103 0.052 111.754 0.063
202106 0.225 114.631 0.265
202109 0.213 115.734 0.248
202112 0.223 117.630 0.256
202203 0.072 121.301 0.080
202206 0.091 125.017 0.098
202209 0.270 125.227 0.291
202212 0.192 125.222 0.207
202303 -0.141 127.348 -0.149
202306 0.227 128.729 0.238
202309 0.070 129.860 0.073
202312 0.236 129.419 0.246
202403 0.246 131.776 0.252
202406 0.391 132.554 0.398
202409 0.360 133.029 0.365
202412 0.218 133.157 0.221
202503 0.027 134.927 0.027

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


iRadimed  (FRA:46K) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


iRadimed Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of iRadimed's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


iRadimed Business Description

Traded in Other Exchanges
Address
1025 Willa Springs Drive, Winter Springs, FL, USA, 32708
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

iRadimed Headlines

No Headlines